Korean firm Rayence unveils first X-ray detector with next-gen technology

South Korea-based company Rayence has successfully applied the 'SPAD-GS' technology to 3D detectors. The technology...

February 24, 2023 | Friday | News
Japan's Olympus buys Korean gastrointestinal stent firm Taewoong Medical for $370 M

Olympus Corporation, a global medtech company headquartered in Japan, has agreed to acquire Taewoong Medical Co.,&n...

February 24, 2023 | Friday | News
Korea proposes use of light to treat wounds, instead of topical ointments

A team of scientists at the Pohang University of Science and Technology (POSTECH) in South Korea has developed an i...

February 23, 2023 | Thursday | News
Korea's GC Biopharma receives WHO prequalification for chickenpox vaccine

GC Biopharma, a leading provider of biopharmaceutical products in South Korea, has announced that the World Health Organ...

February 22, 2023 | Wednesday | News
Uniting microbiome industry leaders in APAC with 'Microbiome Connect: Asia'

With Asia Pacific (APAC) set to experience transformative growth, the need to build meaningful connections with microbio...

February 21, 2023 | Tuesday | News
Korean firms to develop novel microbiome treatment for Parkinson's disease

South Korean startup LISCure Biosciences Inc. has announced a multi-year strategic R&D collaboration with Celltrion ...

February 21, 2023 | Tuesday | News
Anthill and SparkLabs to boost international growth for Indian and Korean startups

Anthill Ventures, an India-headquartered startup accelerator fund and growth ecosystem, and SparkLabs, a renowned global...

February 17, 2023 | Friday | News
Korea's LegoChemBio buys first-in-class antibody from Swiss startup for cancer therapy

South Korea's LegoChem Biosciences Inc. has announced a license agreement with Elthera AG, a biotechnology sta...

February 15, 2023 | Wednesday | News
Korea's HanAll Biopharma invests in American biotech startup Interon

South Korea based HanAll Biopharma is investing in Interon Laboratories, Inc., a US-based biotechnology company focusing...

February 14, 2023 | Tuesday | News
Korea designs smart contact lens for diagnosing and treating glaucoma

A research team at Pohang University of Science and Technology (POSTECH) in South Korea has developed a smart conta...

February 13, 2023 | Monday | News
SK bioscience invests $261 M to establish vaccine-biopharma hub in Korea

SK bioscience, a South Korea-based innovative vaccine and biotech company committed to promoting human health from preve...

February 9, 2023 | Thursday | News
Korea's Wellmarker Bio inks cancer drug trial collaboration with Merck

South Korean firm Wellmarker Bio (WMBIO) has entered a clinical trial collaboration and supply agreement with Merck (kno...

February 10, 2023 | Friday | News
Dutch biotech firm Synaffix announces first partnership with Korean company

Synaffix B.V., a Dutch biotechnology company focused on commercialising its clinical-stage platform technology for the d...

February 8, 2023 | Wednesday | News
Korea's Qurient inks agreement with TB Alliance for new anti-tuberculosis agent

Qurient, a clinical-stage biotechnology company based in South Korea, and TB Alliance, a not-for-profit organisation ded...

February 6, 2023 | Monday | News
Guardant Health strengthens partnership with Korean startup Lunit to enhance cancer biomarker detection

South Korea-based startup Lunit, in partnership with leading precision oncology company Guardant Health in the US, has a...

February 1, 2023 | Wednesday | News
SN BioScience, Boryeong ink licensing agreement of first generic of anti-cancer drug Abraxane in Korea

Biotech startup SN BioScience and pharma major Boryeong have signed a domestic manufacturing technology transfer an...

January 30, 2023 | Monday | News
Korea's Samsung Biologics to continue expansion in capacity, geography and portfolio in 2023

At the 2023 J.P. Morgan Healthcare Conference in January, Samsung Biologics, a fully integrated CDMO offering state...

January 27, 2023 | Friday | News
Korea's GenKOre inks $300 M deal with US to develop in vivo gene-editing therapies

GenKOre, Inc., a Korea-based biotech company with hypercompact CRISPR-Cas tools, has entered into a ...

January 26, 2023 | Thursday | News